The increased risk of developing a ovary tumor in BRCA1/2 mutation carriers, assessed as 15,3% of the whole ovary cancer patients [44], has been related to the different functions of BRCA1 and 2 genes in the regulation of cell growth, genomic stability and repair of genomic damage by homologous recombination. The gene discussed is BRCA1; the disease is ovarian neoplasm.